Alzheimer's disease (AD) pathology is featured by extracellular accumulation of amyloid‐β (Aβ) plaques and intracellular tau neurofibrillary tangles in the brain, and no official approved regimes can change over or arrest the progression of this disease.1 The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.